Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is proud to announce the launch of its D
The Nobel Prize in Physiology or Medicine awarded
This year, the Hamburg based life sciences company
Alembic Pharmaceuticals Ltd., t
Since it’s an ingredient in so many foods, you h
Dear Readers,Welcome to the latest issue of Microb
Researchers in the US have found a potential therapeutic treatment for SARS-CoV-2, the virus which causes COVID-19, along with other coronaviruses. Pathogenic coronaviruses are a major threat to international public health, as shown by the SARS-CoV, MERS-CoV, along with the recently emerged SARS-CoV-2.
All these coronavirus 3C-like proteases, called 3CLpro, are strong therapeutic targets because they play vital roles in coronavirus replication, ” the researchers stated.
“Vaccine developments and treatments are the biggest targets in COVID-19 research, and therapy is actually key,” explained Kyeong-Ok Chang, a professor at Kansas State University in the US.
“This paper clarifies protease inhibitors targeting coronavirus 3CLpro, that can be a well-known therapeutic goal,” Chang explained.
These findings imply that this series of chemicals should be researched further as a potential therapeutic for human coronavirus infection, they said.
